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Background: Belief is that chronic disease prevalence is rising in Bangladesh since death from them has increased.
We reviewed published cardiovascular (CVD) and Type 2 Diabetes Mellitus (T2DM) studies between 1995 and 2010
and conducted a meta-analysis of disease prevalence.
Methods: A systematic search of CVD and T2DM studies yielded 29 eligible studies (outcome: CVD only = 12, T2DM
only = 9, both = 8). Hypertension (HTN) was the primary outcome of CVD studies. HTN and T2DM were defined with
objective measures and standard cut-off values. We assessed the study quality based on sampling frame, sample
size, and disease evaluation. Random effects models calculated pooled disease prevalence (95% confidence interval)
in studies with general population samples (n = 22).
Results: The pooled HTN and T2DM prevalence were 13.7% (12.1%–15.3%) and 6.7% (4.9%–8.6%), respectively.
Both diseases exhibited a secular trend by 5-year intervals between 1995 and 2010 (HTN= 11.0%, 12.8%, 15.3%,
T2DM= 3.8%, 5.3%, 9.0%). HTN was higher in females (M vs. F: 12.8% vs.16.1%) but T2DM was higher in males
(M vs. F: 7.0% vs. 6.2%) (non-significant). Both HTN and T2DM were higher in urban areas (urban vs. rural: 22.2% vs.
14.3% and 10.2% vs. 5.1% respectively) (non-significant). HTN was higher among elderly and among working
professionals. Both HTN and T2DM were higher in ‘high- quality’ studies.
Conclusions: There is evidence of a rising secular trend of HTN and T2DM prevalence in Bangladesh. Future
research should focus on the evolving root causes, incidence, and prognosis of HTN and T2DM.Background
Bangladesh is going through an ‘unsmooth’ epidemio-
logical transition. While the death rate from infectious
diseases has been decreasing slowly – largely due to suc-
cessful immunization programs against childhood infec-
tious disease, widespread use of oral saline for diarrhea,
improvement in sanitation, and the availability of inex-
pensive antibiotics – the mortality rate from chronic dis-
eases has been increasing very rapidly. The International
Center for Diarrheal Diseases in Bangladesh (ICDDR, B),
which has maintained a long standing surveillance site
in rural Bangladesh, reported that 8% of the total deaths
in its surveillance area in 1986 were due to chronic dis-
eases [1]. The proportion of death due to chronic* Correspondence: mrcullen@stanford.edu
†Equal contributors
1School of Medicine, Stanford University, Stanford, USA
Full list of author information is available at the end of the article
© 2012 Saquib et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordiseases increased to 41% by 1996 and 68% by 2006. Fur-
ther, the report made a mortality projection that the
death rate from cardiovascular diseases (CVD) would be
4 times higher in 2010 and 21 times higher in 2025 com-
pared to its corresponding rate in 2003[1]. Bangladesh
has been experiencing rapid urbanization for the past
several decades [2,3], which raises the concern that the
chronic disease burden may be even higher for urban
populations. Unplanned development in the urban areas
has created an environment that is prohibitive and un-
safe for physical activity [4]. Increased access to and
popularity of fast food may also contribute to poorer diet
quality, particularly among the city’s affluent class [5].
Further, high density living has contributed to increased
air pollution in urban areas [6].
Besides the high-mortality rate from chronic diseases,
Bangladeshis are developing these diseases at an earlier
age than in the past. For example, the BangladeshLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Endocrine, and Metabolic Disorders (BIRDEM) patient
registry showed that the mean age at diagnosis for Type
2 Diabetes (T2DM) was significantly lower in 2005 than
in 1995 [7]. Similarly, the INTERHEART Study- a global
case–control study of risk factors for acute myocardial
infarction (MI)- reported that the mean age of MI
among the Bangladeshis (51.9 years) was 6 years lower
than the non-South Asians (58.8) and the lowest among
all South Asians [8]. An analysis of the INTERHEART
control participants further showed that the Banglade-
shis had the highest prevalence of CVD risk factors
among the participating countries: current and former
smoking (59.9%), abdominal obesity (43.3%), self-reported
history of hypertension (14.3%), depression (43%), and
elevated ApoB100/Apo-I ratio (59.6%). Bangladeshis had
the lowest prevalence for regular physical activity (1.3%)
and daily intake of fruits and vegetables (8.6%)[8].
The rising chronic disease burden and high prevalence
of risk factors for these diseases among Bangladeshis
make it imperative that the country undertakes appro-
priate measures to address these problems. A recent
review assessed the ongoing chronic disease programs
(n = 11) in Bangladesh to indentify key priorities for the
country [9]. It concluded that these programs, both gov-
ernmental and non-governmental, partially met five of
the six chronic disease prevention strategies, which were
developed by the World Health Organization (WHO)
and adopted by the Bangladesh government. The only
strategy that had not been met by any of the programs
was the ‘prevention and control of chronic diseases
through the promotion of research’ [9].
If research is to guide future prevention strategies, the
first step is to gather the existing evidence. To this end,
we compiled the results of all research studies on CVD
and T2DM, published in national and international jour-
nals, between 1995 and 2010. We aimed to assess the
prevalence/incidence of diseases and the associated risk
factors reported in these studies. We examined the study
attributes, sampling strategies, participants’ characteristics,
and strata-specific disease estimates. The specific review
objective were: (1) to determine the extent of research
that has been done for each disease, (2) to identify popula-
tions who are at a higher risk of disease, and (3) to recom-
mend the future direction of prevention research efforts.
Methods
Search strategy
We systematically explored both the international
(PubMed) and country specific (BanglaJol) search engines
to locate the relevant articles. We categorized the search
terms according to location, methodology and outcomes:
(1) Location: “Bangladesh.” (2) Method: “prevalence,
cross-sectional, cohort studies, survey.” (3) Outcome:“diabetes, diabetes mellitus, non-insulin dependent dia-
betes mellitus, NIDDM, type 2 diabetes, cardiovascular
disease, CVD, myocardial infarction, ischemic heart dis-
ease, hypertension, high blood pressure, coronary artery
disease”. The “AND” Boolean operator was used to com-
bine search terms across the categories and the “OR”
was used to combine within the categories. Further, we
limited the search to studies that only involved human
participants and were published between January 1, 1995
and December 31, 2010. We screened the studies using
the following inclusion criteria: (1) had prevalence or
incidence data available on either CVD or T2DM,
(2) had selected a sample from within Bangladesh, and
(3) had published results between 1995 and 2010. Once
we identified the eligible studies, we made further exclu-
sions based on sample, study design, and publication type.
We retrieved the full-text for the selected studies either
via the Internet or from the author directly; however, full
text could not be obtained for 5 studies. The prevalence
data for these studies was extracted from the abstract.
Exclusion of studies
We screened 186 articles based on our search results
and 86 of them met our inclusion criteria. Of the 100
ineligible studies, 52 were excluded because they did not
report an estimate of disease prevalence and 48 were
excluded because the samples did not involve Banglade-
shis or included only those living in other countries.
From the 86 eligible studies, we excluded an additional
57 studies for the following reasons: (1) had a sample of
only patients (n = 30) or had calculated prevalence from
the hospital outpatient department (n = 3), (2) had a
case–control design (n = 8), (3) had only mortality data
(n = 3), (4) had data that was published previously
(n = 3), or (5) had a review or letter format (n = 10). The
remaining 29 studies [10-38], were the focus of this re-
view (Figure 1). We specified ‘general population sample’
as the criterion for inclusion in the meta-analysis.
A total of 22 studies were used to calculate the pooled
prevalence. We analyzed the remaining 7 studies, which
sampled special populations (elderly, pregnant, or profes-
sional), separately.
Data extraction
We extracted the following information for each
reviewed study: (1) Authors and publication year,
(2) Title and journal, (3) Study location (urban or rural),
(4), Study design, (5) Sampling strategy (random or non-
random), (6) Sample size, (7) Sample characteristics
such as age and gender, (8) Disease type: CVD [Hyper-
tension (HTN), Ischemic Heart Disease (IHD)] and T2DM
(9) Diagnostic criteria for each disease, (9) Outcome
assessment (objective or subjective), (10) Prevalence
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Figure 1 Consort diagram.
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each disease, and (12) Prevalence of conditions indicating
risk for T2DM: Fasting plasma glucose (FPG), and
Impaired glucose tolerance (IGT).
Quality assessment of studies
We chose three distinct study characteristics to assess the
quality of the reviewed studies. Each study was evaluated
whether it used a random sample (yes = 1, no= 0),
whether it had a sufficient sample size (yes = 1, no= 0),
and whether it assessed disease outcome with an objective
measure (yes= 1, no = 0). The cut-off for a sufficient sam-
ple size was set at 500 participants. With this scoring any
study could tally as high as 3 and as low as 0. Studies that
received 3 points were labeled as ‘high quality’, 2 points as
‘moderate quality’, and 1 point or less as ‘poor quality’.
Analysis plan
We marked the location of the reviewed studies on a
country map, tabulated the study attributes separately by
the disease (Additional file 1: Table S1: CVD, Additional
file 2: Table file S2: T2DM), and coded the estimate for
disease prevalence (HTN, IHD, T2DM). A number of
CVD studies, with HTN as an outcome, did not report
an overall HTN prevalence, but rather reported systolic
and diastolic HTN separately. For these studies, we used
their diastolic HTN values, which were more conserva-
tive than their corresponding systolic HTN values, to
calculate the overall HTN prevalence.We conducted meta-analysis to report the prevalence
of diseases (HTN, T2DM). The methodology that we fol-
lowed for the meta-analysis was described in details by
Neyeloff et al. [39]. Briefly, for each study, we calculated
the following variables: 1) standard error of the preva-
lence, 2) variance, 3) study weights (inversed variance),
4) study weight*prevalence estimate, 5) study weight*
(prevalence estimate)2 and 6) (study weight)2. We used
these variables to estimate Q (measure of heterogeneity
among studies) and I2 (percent between-studies variabil-
ity). Based on Q and I2 values, we chose random effects
models to report pooled prevalence estimates (HTN,
T2DM) and the associated 95% confidence interval (CI).
We followed the same procedures to determine the
stratum-specific pooled prevalence: gender (male vs. fe-
male), study location (urban vs. rural), study quality
(high, moderate, or poor), and time period (1995–2000,
2001–2005, 2006–2010). In addition, we reported pooled
prevalence data on FPG and IGT.
Finally, we extracted HTN and T2DM-specific covari-
ate data. We extracted data on life-style related risk fac-
tors of chronic diseases such as smoking, obesity,
physical activity, fruits and vegetable consumption, and
referenced them in the discussion section.
Results
General characteristics of the reviewed studies (n = 29)
Most studies were conducted in two out of the six divi-
sions in the country. The greatest concentration of
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city of Dhaka (Figure 2). Twenty seven of the 29 studies,
which reported prevalence data (CVD and/or T2DM),
had a cross-sectional design. The remaining two studies
were a prospective cohort and a randomized trial.
Over fifty percent of studies (n = 15) selected partici-
pants with a random procedure, implemented at one of
three levels: village/city ward, household, or individual.
Another eight studies enrolled everyone who resided in
a chosen geographic area and met the study eligibility
criteria; for example, all who were eligible in a village (or
group of villages). Three studies used a non-random
sample and information on the sampling strategy could
not be ascertained for the remaining three studies.
Seventy-five percent of the studies (n = 22) selected the
sample from the general population. The lower age limit
for eligibility was set to 20 in most of these studies, ex-
cept in two where it was 13 and 15, respectively. The
sample of the remaining seven studies came from older
adults (age> 50, n = 3), pregnant women (n = 2), and
working professionals (n = 2). Twenty-five studies had
both male and female participants, 3 studies had onlyDHAKA
CVD study 
Diabetes study 
CVD and Diabetes study 
Figure 2 Map of Bangladesh: Study locations.women, and one did not provide gender information.
Sixteen studies were conducted in rural areas (55%), 8 in
urban areas (28%), and the remaining 5 studies had both
urban and rural samples (17%).
According to the criteria that we used to rate the stud-
ies, 11 were of ‘high quality’ (38%), 12 were of ‘moderate
quality’ (41%), and the remaining 6 were of ‘poor quality’
(21%).
Outcome assessment and definitions
Cardiovascular disease (CVD) was the sole outcome in 12
studies, T2DM alone in 9 studies, and both in the
remaining 8 studies. Twenty-five studies used objective
measures to assess disease status, one used self-report data,
and three studies did not provide adequate information.
The definition of HTN varied across studies: (a) sys-
tolic blood pressure (SBP)≥ 140 mmHg or diastolic
blood pressure (DBP) ≥ 90 mmHg (n = 6), (b) SBP ≥ 140
and/or DBP ≥ 90 and/or anti-hypertensive medication
use (n = 4), (c) SBP ≥ 140 and DBP ≥ 90 (n = 1), (d) SBP ≥
140 (n = 1), (e) DBP ≥ 90 or medication use (n = 1), (f )
SBP ≥ 135 or DBP ≥ 85 (n = 2), (g) self-reported (n = 1),
(h) not specified (n = 4).
All three studies determined IHD through the use of
electrocardiogram. However, only one study provided cri-
teria (the presence of Q wave) as to how it defined IHD.
Most studies defined T2DM according to the World
Health Organization, WHO-1980, the WHO-1999, or
the American Diabetes Association, ADA-1997 classifi-
cation system [40,41]. The definition of T2DM varied
according to whether the test was either a fasting or 2-hr
post glucose and whether the specimen was either blood
or plasma. T2DM was self-reported in one study and not
defined in another study. One study had gestational dia-
betes mellitus (GDM) as its outcome.
Prevalence estimates
HTN (n = 20): (1) General population sample (n = 13):
Overall HTN prevalence estimates ranged from 9.0% to
22.2% (median = 13.3%). The pooled HTN prevalence
was 13.7% (95%CI: 12.1%–15.3%, I2: 95%) (Figure 3, A).
The pooled prevalence within strata was: 12.8% (95%CI:
10.8%–14.7%) for males, 16.1% (95%CI: 13.2%–19.0%)
for females, and 14.3% (95%CI: 12.7%–15.8%) for rural
areas. There was one study in the urban area and
the prevalence was 22.2% (95%CI: 18.7%–25.7%). The
pooled HTN prevalence within each 5-year time period
was: 1995–2000 = 11.0% (95%CI: 9.4%–12.6%), 2001–
2005=12.8% (95%CI: 7.3%–18.3%), and 2006–2010=15.3%
(95%CI: 13.2%–17.5%); and within each category of study
quality was: poor = 12.6% (95%CI: 5.3%–20.0%), moder-
ate = 13.3% (95%CI: 11.7%–14.9%), and high= 15.1%
(95%CI: 10.1%–20.0%) (Figure 4). The between-study vari-
ability (I2) in the strata-specific meta-analyses ranged
Figure 3 Forest Plot of (A) Hypertension (HTN) [10-12,14,15,18,20,23-26,37,38] and (B) Type 2 diabetes mellitus (T2DM)
[10,14,16,20,22,24,25,30-36] studies published between 1995 and 2010. All studies (HTN= 13, T2DM=14) selected samples from the general
adult population. Pooled estimates (red) and 95% CI were calculated with random effect models.
Saquib et al. BMC Public Health 2012, 12:434 Page 5 of 10
http://www.biomedcentral.com/1471-2458/12/434from 74% to 97%. (2) Special population sample (n= 7):
HTN prevalence ranged between 16.8% and 64% in 3
studies of older adults. The prevalence was 5.4% and 9.2%
respectively in 2 studies of pregnant women, and 16.6%
and 17.3% respectively in 2 studies of working profes-
sionals (government employee and health care providers).
IHD (n = 3): IHD prevalence was between 2.7% and
3.4% in two studies with a rural sample and 19.6% with
an urban sample of working professionals.
T2DM (n= 17): (1) General population sample (n = 14):
Overall T2DM prevalence estimates ranged from 2.0% to
21.1% (median= 5.9%). The pooled T2DM prevalence
was 6.7% (95%CI: 4.9%–8.6%, I2: 98%) (Figure 3, B). The
pooled prevalence within strata was: 7.0% (95%CI: 5.1%–
8.9%) for males, 6.2% (95%CI: 4.2%–8.1%) for females,
5.1% (95%CI: 2.9%–7.3%) for rural areas, and 10.2% (95%Figure 4 Pooled estimates of Hypertension (HTN) and Type 2 diabete
and 2006–2010 and (B) study quality: poor, moderate, and high. All st
population. Estimates and 95% CI were calculated with random effect modCI: 6.0%–14.4%) for urban areas. The pooled T2DM
prevalence within each 5-year time period was: 1995–
2000= 3.8% (95%CI: 2.3%–5.3%), 2001–2005= 5.3% (95%
CI: 3.2%–7.4%), and 2006–2010= 9.0% (95%CI: 5.1%–
12.9%); and within each category of study quality was:
moderate = 6.2% (95%CI: 1.7%–10.8%), and high= 6.9%
(95%CI: 4.8%–8.9%) (Figure 4). The between-study vari-
ability (I2) in the strata-specific meta-analyses ranged
from 91% to 99%. (2) Special population sample (n = 3):
T2DM prevalence was 6.8% in one study of pregnant
women, and ranged between 4.5% and 12.3% in two
studies of working professionals.
Covariate assessment
Nine studies reported data on covariates of HTN. Being
female, older, obese, diabetic, having a higher education,s mellitus (T2DM) by (A) 5-year intervals: 1995–2000, 2001–2005,
udies (HTN= 13, T2DM=14) selected samples from the general adult
els.
Saquib et al. BMC Public Health 2012, 12:434 Page 6 of 10
http://www.biomedcentral.com/1471-2458/12/434or from a higher socioeconomic status were significantly
associated with a higher prevalence of HTN. Addition-
ally, urban dwelling was reported to be associated with a
higher prevalence of HTN in one study and with a lower
prevalence in another study. Further, the studies that
were conducted in arsenic contaminated areas reported
a dose–response relationship between arsenic exposure
and HTN; the prevalence of HTN increased incremen-
tally across the exposure categories.
Ten studies reported T2DM-related covariate data.
Being male, older, obese (both general and central), hyper-
tensive, having a sedentary lifestyle, having a family his-
tory of diabetes, and a higher socioeconomic status were
significantly associated with higher prevalence of diabetes.
Discussion
Secular trend
The meta-analyses of the prevalence data suggest a rising
secular trend of chronic disease in Bangladesh. For both
HTN and T2DM, the pooled prevalence estimates were
lowest during 1995–2000, highest during 2006–2010, and
in-between during 2001–2005 (Figure 4). Compared with
the estimates during 1995–2000, those during 2001–2005
were non-significantly higher and those during 2006–
2010 were significantly higher. This supports the ‘epi-
demiological disease shift’ reported previously, which
showed an increase in death due to chronic diseases with
a concomitant decrease in death due to infectious dis-
eases [1]. The rising trend of HTN and T2DM could be
explained, in part, by the increased life expectancy of the
Bangladeshi population as well as the increased presence
of known risk factors for chronic diseases. Between 1995
and 2010, the mean life expectancy has risen by approxi-
mately 6 years (62.1 to 68.3 years) [42]. Also, Bangladeshis
rank highest among South Asians in terms of tobacco
use, physical inactivity, and poor dietary habits [8]. We
anticipated that methodological differences such as
sample selection and diagnostic criteria across the studies
could influence the estimate of the secular trend. There-
fore, we limited our analysis to only those studies
that selected a sample from the general population. Fur-
ther, the cut-off value of systolic (140 mmHg) and dia-
stolic (90 mmHg) blood pressure used to define HTN
did not change during the review period. We acknow-
ledge that the diagnostic criteria [43,44] for T2DM have
become less stringent during this time period but this
small change alone is unlikely to explain the two-fold rise
in the T2DM prevalence.
Disease comparison
The HTN prevalence that we found in this review is
comparable to the HTN prevalence reported in the other
South-Asian Countries, [45-53]. Although a formal com-
parison among these countries does not fall within thescope of this review, it is worthwhile to compare the
data between Bangladesh and India, as they are geo-
graphically contiguous, share common traits in culture,
and have similar life expectancy and chronic disease risk
factor profiles [8,42]. For example, the HTN prevalence
in the rural (pooled: 14.3%) and urban (single study:
22.2%) Bangladesh is well within the range of prevalence
estimates for rural (12%–17%) and urban (20%–40%)
India [46]. Similarly, the IHD prevalence in the rural
areas is comparable between the two countries (Bangla-
desh = 2.7%–3.4% vs. India = 3%–4%) [12,20,21,48,54].
The estimates for the urban areas cannot be compared
because the Bangladesh estimate (19.6%) comes from
only one study, which selected a small sample from a
special population (government employees) [27].
The rising HTN prevalence in Bangladesh is worri-
some since a large segment of the population is unaware
that they have HTN and since many HTN patients do
not have their blood pressure properly managed with
medication. Between fifty and eighty-five percent of the
participants who were diagnosed with HTN did not
know they had HTN prior to the study assessment [55].
Although allopathic anti-HTN medication use (97%) is
the norm among those who were diagnosed with HTN,
only a quarter of them were found to have their blood
pressure controlled with medication. Since uncontrolled
HTN is a major risk factor for myocardial infarction
(MI), it may partly explain why Bangladeshis have the
lowest mean age for the development of MI among the
nations of the world [8].
Similar to HTN and IHD, the T2DM prevalence in
Bangladesh is also comparable to the corresponding esti-
mates from other South-Asian countries such as India
[45]. Although, in both countries, the prevalence is low
in the rural areas (Bangladesh = 5.1%, India = 3.8%), it is
considerably higher in the urban areas (Bangladesh =
10.2%, India = 11.8%) [45]. At the same time a significant
portion of the population have conditions such as IFG or
IGT, and therefore are at risk of developing T2DM
[14,30,35]. For example, in our reviewed studies, the
pooled prevalence for IFG and IGT were found 7.0%
(95%CI: 3.2%–10.8%, I2 = 99%) and 8.2% (95%CI: 3.9%–
12.4%, I2 = 99%), respectively [10,16,22,25,30,31,33,35,36].
Of all the factors that may be contributing to the rise
of HTN and T2DM in Bangladesh, behavioral risk fac-
tors are likely to be the most salient. A recent review
suggests that 90% of the chronic diseases among the
South-Asians are attributable to life-style factors [54].
Survey-data indicates that between 47% and 63% of men
and less than 3% of women in Bangladesh are daily smo-
kers [14,55-57]. A significant portion of these smokers
uses filter-less cigarettes. Further, smoke-less tobacco
use (with bettle-leaf or chewed/sniffed in the powdered
form) is quite common (30%) in the population,
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ive of gender [57]. Bangladeshis also rank highest among
the South Asians in terms of physical inactivity and low
intake of fruits and vegetables [58,59]. And, although
the overweight prevalence is relatively low (men = 10%,
women = 15%), a large portion of Bangladeshis are,
in fact, centrally obese (men = 25%, women = 60%)
[34,35,60].
Strengths and limitations of the reviewed studies
It is notable that dozens of studies have been conducted
in the last fifteen years to assess the risk factors and
overall burden of chronic disease in Bangladesh, despite
it being one of the poorest countries in the world
and having little allocation of government funding for
research. Many adopted a unique sampling strategy, in
which they selected a village or a group of villages and
enrolled all eligible participants. This particular strategy
ensured that each study, besides having a robust sample,
also had adequate representation in age, gender, and
socioeconomic strata. Studies were also conducted in
special populations such as pregnant women [17], health
care professionals [28], government employees [27], and
slum dwellers [32]. Inclusion of both urban and rural
samples enabled a few studies to make a direct compari-
son of disease prevalence and risk factors between these
two groups [14,55]. Objective measurement (such as
blood pressure measurement, echocardiogram, or blood
analysis) of disease outcomes was common to most
studies. Further, studies clearly defined the eligibility cri-
teria and included relevant covariate data.
A general limitation of the reviewed studies was a lack
of representative study samples in the urban areas. For
example, the studies that were conducted in the capital
have recruited participants either sharing a common liv-
ing environment[32] (e.g. slum dwellers) or a common
profession [28] (e.g. health care workers). Such samples
are unlikely to provide a true estimate of CVD or T2DM
prevalence for a city with 12–15 million residents living
in a wide range of socioeconomic and environmental
conditions. On a similar note, using a single or a group
of villages in a certain geographic location may not cap-
ture the disease prevalence for a country with approxi-
mately 68 thousand villages.
Strengths and limitations of the review
By categorizing the studies according to the markers of
good study design (random sample, sufficient sample
size, objective measure), we showed that the disease
prevalence varied by the study quality. The prevalence
was generally higher in ‘high-quality’ studies than in
‘poor-quality studies’, for both HTN and T2DM. We con-
ducted meta-analyses to calculate the pooled prevalence
of disease. However, data interpretation should be donecautiously since the heterogeneity (between-study vari-
ability) was very high, despite the use of random effects
models to accommodate this variability. A limitation is
the small number of studies, which have prevented us
from stratifying the time trend analysis by study quality.
A general difficulty of this project was to gather all the
published data on CVD and T2DM for the review
period, since not all Bangladeshi journals are available
electronically, and those that have electronic text came
into existence recently. Although we were able to collect
a number of full text articles that were otherwise un-
available in the Web through personal communications
with Bangladeshi researchers, we had to rely on the
abstract for a few studies. In most cases, the information
needed for the quality rating was available in the abstract
and in the two instances where it was missing, we have
imputed with the lower (i.e. more conservative) value.
There may also be unpublished disease prevalence data
that we have missed in our review.
Recommendations
Although an adequate number of HTN prevalence stud-
ies have been conducted, they were mostly done in and
around Dhaka city, leaving many regions of the country
unstudied. Little data exist on the prevalence of other
cardiovascular diseases such as ischemic heart disease.
Further, we did not find prevalence data on rheumatic
heart disease or tuberculous pericardial disease, despite
the fact that many Bangladeshis, especially the slum
dwellers, suffer from poor nutrition and live in unsani-
tary conditions -- both of which have been associated
with the development of these diseases. No study has
reported to date the impact of nutritional (i.e. sodium,
refined sugar intake), occupational, and various environ-
mental factors (i.e. migration to the city, salination of
drinking water, air pollution) on CVD or T2DM. It is
important that these issues be explored for a number of
reasons: (1) the urban population has been growing on
an average of 3.5% a year [61], (2) food and drinking
water in the coastal area has been greatly affected by a
rise in salinity [62,63], and (3) the urban areas have seen
a decline in air quality [6].
We recommend that future prevalence studies focus
on the gaps identified in this review. In addition, we sug-
gest that samples of the future studies are selected sys-
tematically, according to the administrative structure of
the country (division, district, sub-district, etc.), in order
to capture any differences in disease prevalence by geo-
graphical regions. We did not find any longitudinal co-
hort studies on CVD or T2DM. This is a significant gap
in the knowledge and understanding of these chronic
diseases in the context of Bangladesh. Such studies
would provide essential information on the incidence of
these diseases, their associated risk factors, and the
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http://www.biomedcentral.com/1471-2458/12/434groups that are at higher risk of developing them. Fur-
ther, longitudinal data are necessary to understand dis-
ease progression and prognosis.
We recognize the potential challenges to conducting
cohort studies in Bangladesh. Long-term follow-up of
participants may be difficult. In the urban areas, many
people are either renters or slum dwellers who change
their residence frequently. A similar challenge may arise
in rural areas as there is constant migration to the cities
for employment. Other challenges include the absence
of either disease/death registries or electronic medical
records. We acknowledge that the development of a
cohort study would require considerable effort and data
would not be available for many years. In the meantime,
retrospective cohort studies could be conducted using
medical records available in various government
(NICVD-National Institute of Cardiovascular Diseases)
and private institutions (ICDDR,B-International Center on
Diarrheal Diseases and Research, Bangladesh; BIRDEM-
Bangladesh Institute of Research and Rehabilitation for
Diabetes, Endocrine, and Metabolic Disorders; NHF-
National Heart Foundation). Such retrospective studies
could begin to address some of the research issues
outlined above such as disease complications and treat-
ment adherence.Conclusions
This review of the Bangladeshi research studies on CVD
and T2DM between 1995 and 2010 concludes that the
prevalence of HTN and T2DM in the population is sig-
nificant and that there is evidence of a rising secular
trend for these two diseases. The disease prevalence was
higher in older adults, women, and those living in urban
areas. Also, established risk factors for HTN and T2DM
such as smoking and central obesity are already wide-
spread in the population. Further, significant proportions
of Bangladeshis are either physically inactive, inadequate
in their intake of fruits and vegetables or both. Appro-
priate research could provide the foundation for devel-
oping effective policies and intervention strategies
to address the growing epidemic of HTN and T2DM
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